Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

NeuroOne Medical Technologies Corporation (NMTC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.6500+0.0700 (+4.43%)
At close: 04:00PM EDT
1.5900 -0.06 (-3.64%)
After hours: 05:15PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.5800
Open1.5400
Bid1.5000 x 1100
Ask1.7900 x 3000
Day's Range1.5400 - 1.6600
52 Week Range0.5100 - 4.2300
Volume13,196
Avg. Volume196,396
Market Cap26.71M
Beta (5Y Monthly)0.73
PE Ratio (TTM)N/A
EPS (TTM)-1.7760
Earnings DateDec 13, 2022 - Dec 19, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.63
  • PR Newswire

    NeuroOne Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective September 20, 2022, the Compensation Committee of the Board of Directors approved two equity awards under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan (the "Inducement Plan"), as a material inducement to the individuals en

  • PR Newswire

    NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

    NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the third quarter of fiscal year 2022 ended June 30, 2022.

  • PR Newswire

    NeuroOne® Submits Special 510(k) to FDA for Evo® sEEG Electrode

    NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that the Company submitted a special 510(k) to the U.S. Food and Drug Administration ("FDA") on August 8th for its sEEG electrode to extend the duration of use from less than 24 hours to less than 30 day use. A special 510(k), according to FDA guidance, is us

Advertisement
Advertisement